<DOC>
	<DOCNO>NCT00844454</DOCNO>
	<brief_summary>The purpose study compare effectiveness percutaneous ethanol ablation use multi-pronged needle ( QFEA ) percutaneous radiofrequency ablation ( RFA ) treatment early-stage hepatocellular carcinoma ( HCC ) .</brief_summary>
	<brief_title>Multi-pronged Ethanol Ablation Radiofrequency Ablation Early-stage Hepatocellular Carcinoma</brief_title>
	<detailed_description>Patients early-stage ( single tumor 5 cm 3 tumor 3 cm size ) primary hepatocellular carcinoma randomize two percutaneous ablation treatment arm , include radiofrequency ablation multi-pronged ethanol ablation . The local treatment response , complication , long-term disease-free survival overall survival analyze .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<criteria>Primary hepatocellular carcinoma , single tumor ≤5 cm 3 tumor ≤3 cm Ultrasound detectable tumor Liver function classify ChildPugh A B Platelet count ＞ 50,000/mm3 , prothrombin activity ＞ 50 % Not suitable resection patient refuse surgery Vascular invasion extrahepatic spread Patients allergic ethanol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>hepatocellular carcinoma</keyword>
	<keyword>PEI</keyword>
	<keyword>RF ablation</keyword>
	<keyword>tumor ablation</keyword>
</DOC>